Courses

← vista completa

Published on December 1, 2004 | http://doi.org/10.5867/medwave.2004.11.3226

Glucocorticoid-induced osteoporosis in the elderly

Osteoporosis inducida por glucocorticoides en el adulto mayor

Marina Arriagada

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Marina Arriagada

Clínica de Reumatología y Rehabilitación, CLINDER, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Arriagada M. Glucocorticoid-induced osteoporosis in the elderly. Medwave 2004;4(11):e3226 doi: 10.5867/medwave.2004.11.3226

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/12/2004

Index

Metrics

Not available at the moment.

Notes

References

  1. ACR Task Force on Osteoporosis Guidelines: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum. 1996 Nov;39(11):1791-801. | CrossRef | PubMed
  2. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med. 1997 Aug 7;337(6):382-7. | CrossRef | PubMed
  3. Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, et al. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum. 2001 Jan;44(1):202-11. | CrossRef | PubMed
  4. Amin S. A meta-analysis ranking efficacy of treatments for corticosteroid-induced osteoporosis. Arthritis Rheum 1998;41(suppl 9):5137.
  5. Arriagada M. Inflammatory Rheumatic Diseases and Osteoporosis Proceedings. XIX ILAR Congress of Rheumatology Communications Consultants, Singapore 1997:292-296.
  6. Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum. 1999 Nov;42(11):2309-18. | CrossRef | PubMed
  7. Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res. 2001 Jan;16(1):97-103. | CrossRef | PubMed
  8. Eastell R. Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. J Intern Med. 1995 May;237(5):439-47. | CrossRef | PubMed
  9. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med. 1998 Oct;244(4):271-92. | CrossRef | PubMed
  10. Gulko PS, Mulloy AL. Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment. Clin Exp Rheumatol. 1996 Mar-Apr;14(2):199-206. | PubMed
  11. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest. 1998 Oct 15;102(8):1627-33. | CrossRef | PubMed
  12. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res. 1999 Jul;14(7):1061-6. | CrossRef | PubMed
  13. Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res. 2000 Jun;15(6):1006-13. | CrossRef | PubMed
  14. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998 Jul 30;339(5):292-9. | CrossRef | PubMed
  15. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993 Jun 17;328(24):1747-52. | CrossRef | PubMed
  16. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003 Nov;48(11):3224-9. | CrossRef | PubMed